The Sunshine Act has caused a great deal of activity in the Life Sciences industry. You need to understand the law and its exact requirements as well as the impact this mandate will have on your operations and corporate culture.
Key Learning Points
As your organization addresses the Sunshine Act, many questions may begin to surface:
- Where do we start? How do we begin to address this requirement?
- What business processes and systems are involved?
- What is the common way and/or the most effective way to address the act?
- How do we make the process scalable for international and global changes?
- How do we strike the balance between compliance and administrative burden on our people?
- How do we communicate all this to our employees?
Register today for this 90-minute webinar and our experts will guide you through a recommended approach to respond to and address these questions, and will provide you with information that helps you comply with the Sunshine Act from a process and systems perspective.
Your Experts
Tina Fan, Director, Acquis Consulting Group
Acquis Consulting Group is a boutique management consulting firm that focuses on the alignment of business and operational strategy. Acquis was founded in 1998 and is based in New York City.
Acquis Consulting Group has been partnering with companies in the Life Sciences industry for the past twelve years and is focused on helping organizations strengthen their compliance programs. Companies that are affected by the HCP Sunshine Act can benefit from Acquis’s expertise in Project Management, Systems Integration, Risk Mitigation Planning, Expense Management, and Business Intelligence Strategy.
Doug Baden, Director, Corporate Quality & Compliance Solutions at St. Jude Medical, Inc.
St. Jude Medical develops medical technology and services that focus on putting more control into the hands of those who treat cardiac, neurological and chronic pain patients worldwide. The company is dedicated to advancing the practice of medicine by reducing risk wherever possible and contributing to successful outcomes for every patient. The St. Jude Medical product portfolio includes implantable cardioverter defibrillators (ICDs), cardiac resynchronization therapy (CRT) devices, pacemakers, electrophysiology catheters, mapping and visualization systems, vascular closure devices, structural heart products, spinal cord stimulation and deep brain stimulation devices.
